Publications
titanium dioxide (5 POSTS)
2024 (1 POST)
Oral exposure to titanium dioxide (TiO2): Comparison of adverse outcome pathway (AOP) key event (KE) effect levels to human daily dietary exposures
Donnell MT, Keeton KA, Covell L, Madl AK. Oral exposure to titanium dioxide (TiO2): Comparison of adverse outcome pathway (AOP) key event (KE) effect levels to human daily dietary exposures. Poster presentation P190 at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, March 2024. In: The Toxicologist 198(S1):130, Abstract 3087.
View Abstract2023 (1 POST)
Effect of addition of titanium dioxide nanoparticles on the antimicrobial properties, surface roughness and surface hardness of polymethyl methacrylate: A systematic review
Kaurani P, Hindocha AD, Jayasinghe RM, Pai UY, Batra K, Price C. 2023. Effect of addition of titanium dioxide nanoparticles on the antimicrobial properties, surface roughness and surface hardness of polymethyl methacrylate: A systematic review. F1000Res 12:577; doi: 10.12688/f1000research.130028.1.
View Abstract2016 (1 POST)
Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations
Thompson CM, Suh M, Mittal L, Wikoff D, Welsh B, Proctor DM. 2016. Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations. Regul Toxicol Pharmacol 80(Oct):60-70; doi: 10.1016/j.yrtph.2016.05.031.
View Abstract2015 (1 POST)
Inhalation cancer risk assessment of titanium dioxide
Proctor D, Suh M, Thompson C, Hixon, G. Inhalation cancer risk assessment of titanium dioxide. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract2007 (1 POST)
An approach to risk assessment for TiO2
Dankovic D, Kuempel E, Wheeler MW. 2007. An approach to risk assessment for TiO2. Inhal Toxicol 19(sup1):205-12; doi: 10.1080/08958370701497754. PMID: 17886069.
View Abstract